nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—CYP2D6—Alzheimer's disease	0.385	1	CbGaD
Betaxolol—CYP2D6—Rivastigmine—Alzheimer's disease	0.135	0.432	CbGbCtD
Betaxolol—CYP2D6—Donepezil—Alzheimer's disease	0.108	0.345	CbGbCtD
Betaxolol—CYP2D6—Galantamine—Alzheimer's disease	0.0697	0.223	CbGbCtD
Betaxolol—Chlorphenesin—BCHE—Alzheimer's disease	0.000795	0.222	CrCbGaD
Betaxolol—Bisoprolol—CYP2D6—Alzheimer's disease	0.000425	0.119	CrCbGaD
Betaxolol—Acebutolol—CYP2D6—Alzheimer's disease	0.000403	0.112	CrCbGaD
Betaxolol—Oxprenolol—CYP2D6—Alzheimer's disease	0.0004	0.112	CrCbGaD
Betaxolol—Chlorphenesin—PTGS2—Alzheimer's disease	0.000366	0.102	CrCbGaD
Betaxolol—Alprenolol—CYP2D6—Alzheimer's disease	0.000366	0.102	CrCbGaD
Betaxolol—Conjunctivitis—Memantine—Alzheimer's disease	0.000343	0.00125	CcSEcCtD
Betaxolol—Cough—Galantamine—Alzheimer's disease	0.000341	0.00125	CcSEcCtD
Betaxolol—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.00034	0.00124	CcSEcCtD
Betaxolol—Metoprolol—CYP2D6—Alzheimer's disease	0.00034	0.0949	CrCbGaD
Betaxolol—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000338	0.00123	CcSEcCtD
Betaxolol—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000338	0.00123	CcSEcCtD
Betaxolol—Visual impairment—Donepezil—Alzheimer's disease	0.000336	0.00123	CcSEcCtD
Betaxolol—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000335	0.00122	CcSEcCtD
Betaxolol—Chest pain—Galantamine—Alzheimer's disease	0.000333	0.00122	CcSEcCtD
Betaxolol—Arthralgia—Galantamine—Alzheimer's disease	0.000333	0.00122	CcSEcCtD
Betaxolol—Myalgia—Galantamine—Alzheimer's disease	0.000333	0.00122	CcSEcCtD
Betaxolol—Epistaxis—Memantine—Alzheimer's disease	0.000332	0.00121	CcSEcCtD
Betaxolol—Anxiety—Galantamine—Alzheimer's disease	0.000332	0.00121	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000331	0.00121	CcSEcCtD
Betaxolol—Sinusitis—Memantine—Alzheimer's disease	0.000331	0.00121	CcSEcCtD
Betaxolol—Sweating—Rivastigmine—Alzheimer's disease	0.00033	0.00121	CcSEcCtD
Betaxolol—Discomfort—Galantamine—Alzheimer's disease	0.000329	0.0012	CcSEcCtD
Betaxolol—Agranulocytosis—Memantine—Alzheimer's disease	0.000329	0.0012	CcSEcCtD
Betaxolol—Dry mouth—Galantamine—Alzheimer's disease	0.000326	0.00119	CcSEcCtD
Betaxolol—Epistaxis—Rivastigmine—Alzheimer's disease	0.000325	0.00119	CcSEcCtD
Betaxolol—Tinnitus—Donepezil—Alzheimer's disease	0.000325	0.00119	CcSEcCtD
Betaxolol—Sinusitis—Rivastigmine—Alzheimer's disease	0.000323	0.00118	CcSEcCtD
Betaxolol—Confusional state—Galantamine—Alzheimer's disease	0.000322	0.00118	CcSEcCtD
Betaxolol—Bradycardia—Memantine—Alzheimer's disease	0.000322	0.00118	CcSEcCtD
Betaxolol—Rhinitis—Memantine—Alzheimer's disease	0.000317	0.00116	CcSEcCtD
Betaxolol—Bradycardia—Rivastigmine—Alzheimer's disease	0.000315	0.00115	CcSEcCtD
Betaxolol—Hypoaesthesia—Memantine—Alzheimer's disease	0.000315	0.00115	CcSEcCtD
Betaxolol—Hallucination—Memantine—Alzheimer's disease	0.000315	0.00115	CcSEcCtD
Betaxolol—Pindolol—CYP2D6—Alzheimer's disease	0.000314	0.0878	CrCbGaD
Betaxolol—Shock—Galantamine—Alzheimer's disease	0.000314	0.00115	CcSEcCtD
Betaxolol—Pharyngitis—Memantine—Alzheimer's disease	0.000314	0.00115	CcSEcCtD
Betaxolol—Nervous system disorder—Galantamine—Alzheimer's disease	0.000313	0.00114	CcSEcCtD
Betaxolol—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000313	0.00114	CcSEcCtD
Betaxolol—Chills—Donepezil—Alzheimer's disease	0.000313	0.00114	CcSEcCtD
Betaxolol—Tachycardia—Galantamine—Alzheimer's disease	0.000312	0.00114	CcSEcCtD
Betaxolol—Arrhythmia—Donepezil—Alzheimer's disease	0.000311	0.00114	CcSEcCtD
Betaxolol—Rhinitis—Rivastigmine—Alzheimer's disease	0.00031	0.00113	CcSEcCtD
Betaxolol—Skin disorder—Galantamine—Alzheimer's disease	0.00031	0.00113	CcSEcCtD
Betaxolol—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000309	0.00113	CcSEcCtD
Betaxolol—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000308	0.00112	CcSEcCtD
Betaxolol—Hallucination—Rivastigmine—Alzheimer's disease	0.000308	0.00112	CcSEcCtD
Betaxolol—Alopecia—Donepezil—Alzheimer's disease	0.000308	0.00112	CcSEcCtD
Betaxolol—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000307	0.00112	CcSEcCtD
Betaxolol—Mental disorder—Donepezil—Alzheimer's disease	0.000305	0.00111	CcSEcCtD
Betaxolol—Visual impairment—Memantine—Alzheimer's disease	0.000305	0.00111	CcSEcCtD
Betaxolol—Anorexia—Galantamine—Alzheimer's disease	0.000304	0.00111	CcSEcCtD
Betaxolol—Erythema—Donepezil—Alzheimer's disease	0.000303	0.00111	CcSEcCtD
Betaxolol—Malnutrition—Donepezil—Alzheimer's disease	0.000303	0.00111	CcSEcCtD
Betaxolol—Hypotension—Galantamine—Alzheimer's disease	0.000298	0.00109	CcSEcCtD
Betaxolol—Visual impairment—Rivastigmine—Alzheimer's disease	0.000298	0.00109	CcSEcCtD
Betaxolol—Tension—Donepezil—Alzheimer's disease	0.000298	0.00109	CcSEcCtD
Betaxolol—Dysgeusia—Donepezil—Alzheimer's disease	0.000297	0.00108	CcSEcCtD
Betaxolol—Eye disorder—Memantine—Alzheimer's disease	0.000296	0.00108	CcSEcCtD
Betaxolol—Tinnitus—Memantine—Alzheimer's disease	0.000295	0.00108	CcSEcCtD
Betaxolol—Nervousness—Donepezil—Alzheimer's disease	0.000295	0.00108	CcSEcCtD
Betaxolol—Flushing—Memantine—Alzheimer's disease	0.000294	0.00107	CcSEcCtD
Betaxolol—Cardiac disorder—Memantine—Alzheimer's disease	0.000294	0.00107	CcSEcCtD
Betaxolol—Muscle spasms—Donepezil—Alzheimer's disease	0.000292	0.00106	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000291	0.00106	CcSEcCtD
Betaxolol—Eye disorder—Rivastigmine—Alzheimer's disease	0.000289	0.00106	CcSEcCtD
Betaxolol—Insomnia—Galantamine—Alzheimer's disease	0.000289	0.00105	CcSEcCtD
Betaxolol—Tinnitus—Rivastigmine—Alzheimer's disease	0.000289	0.00105	CcSEcCtD
Betaxolol—Flushing—Rivastigmine—Alzheimer's disease	0.000287	0.00105	CcSEcCtD
Betaxolol—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000287	0.00105	CcSEcCtD
Betaxolol—Angiopathy—Memantine—Alzheimer's disease	0.000287	0.00105	CcSEcCtD
Betaxolol—Paraesthesia—Galantamine—Alzheimer's disease	0.000287	0.00105	CcSEcCtD
Betaxolol—Vision blurred—Donepezil—Alzheimer's disease	0.000286	0.00104	CcSEcCtD
Betaxolol—Immune system disorder—Memantine—Alzheimer's disease	0.000286	0.00104	CcSEcCtD
Betaxolol—Mediastinal disorder—Memantine—Alzheimer's disease	0.000285	0.00104	CcSEcCtD
Betaxolol—Tremor—Donepezil—Alzheimer's disease	0.000284	0.00104	CcSEcCtD
Betaxolol—Chills—Memantine—Alzheimer's disease	0.000284	0.00104	CcSEcCtD
Betaxolol—Arrhythmia—Memantine—Alzheimer's disease	0.000283	0.00103	CcSEcCtD
Betaxolol—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000281	0.00103	CcSEcCtD
Betaxolol—Dyspepsia—Galantamine—Alzheimer's disease	0.000281	0.00103	CcSEcCtD
Betaxolol—Angiopathy—Rivastigmine—Alzheimer's disease	0.000281	0.00102	CcSEcCtD
Betaxolol—Anaemia—Donepezil—Alzheimer's disease	0.00028	0.00102	CcSEcCtD
Betaxolol—Alopecia—Memantine—Alzheimer's disease	0.00028	0.00102	CcSEcCtD
Betaxolol—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000279	0.00102	CcSEcCtD
Betaxolol—Chills—Rivastigmine—Alzheimer's disease	0.000278	0.00101	CcSEcCtD
Betaxolol—Decreased appetite—Galantamine—Alzheimer's disease	0.000278	0.00101	CcSEcCtD
Betaxolol—Mental disorder—Memantine—Alzheimer's disease	0.000277	0.00101	CcSEcCtD
Betaxolol—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000276	0.00101	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000276	0.00101	CcSEcCtD
Betaxolol—Malnutrition—Memantine—Alzheimer's disease	0.000275	0.001	CcSEcCtD
Betaxolol—Fatigue—Galantamine—Alzheimer's disease	0.000275	0.001	CcSEcCtD
Betaxolol—Malaise—Donepezil—Alzheimer's disease	0.000274	0.000998	CcSEcCtD
Betaxolol—Alopecia—Rivastigmine—Alzheimer's disease	0.000273	0.000998	CcSEcCtD
Betaxolol—Constipation—Galantamine—Alzheimer's disease	0.000273	0.000997	CcSEcCtD
Betaxolol—Vertigo—Donepezil—Alzheimer's disease	0.000272	0.000994	CcSEcCtD
Betaxolol—Syncope—Donepezil—Alzheimer's disease	0.000272	0.000993	CcSEcCtD
Betaxolol—Mental disorder—Rivastigmine—Alzheimer's disease	0.000271	0.000989	CcSEcCtD
Betaxolol—Tension—Memantine—Alzheimer's disease	0.00027	0.000986	CcSEcCtD
Betaxolol—Dysgeusia—Memantine—Alzheimer's disease	0.00027	0.000984	CcSEcCtD
Betaxolol—Malnutrition—Rivastigmine—Alzheimer's disease	0.000269	0.000983	CcSEcCtD
Betaxolol—Erythema—Rivastigmine—Alzheimer's disease	0.000269	0.000983	CcSEcCtD
Betaxolol—Nervousness—Memantine—Alzheimer's disease	0.000267	0.000976	CcSEcCtD
Betaxolol—Loss of consciousness—Donepezil—Alzheimer's disease	0.000267	0.000973	CcSEcCtD
Betaxolol—Cough—Donepezil—Alzheimer's disease	0.000265	0.000966	CcSEcCtD
Betaxolol—Tension—Rivastigmine—Alzheimer's disease	0.000264	0.000965	CcSEcCtD
Betaxolol—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000264	0.000963	CcSEcCtD
Betaxolol—Feeling abnormal—Galantamine—Alzheimer's disease	0.000263	0.000961	CcSEcCtD
Betaxolol—Nervousness—Rivastigmine—Alzheimer's disease	0.000262	0.000955	CcSEcCtD
Betaxolol—Vision blurred—Memantine—Alzheimer's disease	0.00026	0.000947	CcSEcCtD
Betaxolol—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000259	0.000945	CcSEcCtD
Betaxolol—Arthralgia—Donepezil—Alzheimer's disease	0.000258	0.000942	CcSEcCtD
Betaxolol—Chest pain—Donepezil—Alzheimer's disease	0.000258	0.000942	CcSEcCtD
Betaxolol—Myalgia—Donepezil—Alzheimer's disease	0.000258	0.000942	CcSEcCtD
Betaxolol—Tremor—Memantine—Alzheimer's disease	0.000258	0.000942	CcSEcCtD
Betaxolol—Anxiety—Donepezil—Alzheimer's disease	0.000257	0.000939	CcSEcCtD
Betaxolol—Ill-defined disorder—Memantine—Alzheimer's disease	0.000256	0.000932	CcSEcCtD
Betaxolol—Discomfort—Donepezil—Alzheimer's disease	0.000255	0.000931	CcSEcCtD
Betaxolol—Anaemia—Memantine—Alzheimer's disease	0.000255	0.000929	CcSEcCtD
Betaxolol—Vision blurred—Rivastigmine—Alzheimer's disease	0.000254	0.000927	CcSEcCtD
Betaxolol—Dry mouth—Donepezil—Alzheimer's disease	0.000253	0.000922	CcSEcCtD
Betaxolol—Body temperature increased—Galantamine—Alzheimer's disease	0.000252	0.000921	CcSEcCtD
Betaxolol—Tremor—Rivastigmine—Alzheimer's disease	0.000252	0.000921	CcSEcCtD
Betaxolol—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00025	0.000912	CcSEcCtD
Betaxolol—Confusional state—Donepezil—Alzheimer's disease	0.00025	0.000911	CcSEcCtD
Betaxolol—Anaemia—Rivastigmine—Alzheimer's disease	0.000249	0.000909	CcSEcCtD
Betaxolol—Malaise—Memantine—Alzheimer's disease	0.000248	0.000906	CcSEcCtD
Betaxolol—Oedema—Donepezil—Alzheimer's disease	0.000248	0.000903	CcSEcCtD
Betaxolol—Vertigo—Memantine—Alzheimer's disease	0.000247	0.000903	CcSEcCtD
Betaxolol—Syncope—Memantine—Alzheimer's disease	0.000247	0.000901	CcSEcCtD
Betaxolol—Infection—Donepezil—Alzheimer's disease	0.000246	0.000897	CcSEcCtD
Betaxolol—Shock—Donepezil—Alzheimer's disease	0.000244	0.000889	CcSEcCtD
Betaxolol—Palpitations—Memantine—Alzheimer's disease	0.000243	0.000888	CcSEcCtD
Betaxolol—Malaise—Rivastigmine—Alzheimer's disease	0.000243	0.000887	CcSEcCtD
Betaxolol—Nervous system disorder—Donepezil—Alzheimer's disease	0.000243	0.000886	CcSEcCtD
Betaxolol—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000242	0.000884	CcSEcCtD
Betaxolol—Vertigo—Rivastigmine—Alzheimer's disease	0.000242	0.000883	CcSEcCtD
Betaxolol—Loss of consciousness—Memantine—Alzheimer's disease	0.000242	0.000883	CcSEcCtD
Betaxolol—Syncope—Rivastigmine—Alzheimer's disease	0.000242	0.000882	CcSEcCtD
Betaxolol—Cough—Memantine—Alzheimer's disease	0.00024	0.000877	CcSEcCtD
Betaxolol—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000239	0.000873	CcSEcCtD
Betaxolol—Palpitations—Rivastigmine—Alzheimer's disease	0.000238	0.000869	CcSEcCtD
Betaxolol—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000237	0.000864	CcSEcCtD
Betaxolol—Anorexia—Donepezil—Alzheimer's disease	0.000236	0.000861	CcSEcCtD
Betaxolol—Hypersensitivity—Galantamine—Alzheimer's disease	0.000235	0.000859	CcSEcCtD
Betaxolol—Cough—Rivastigmine—Alzheimer's disease	0.000235	0.000858	CcSEcCtD
Betaxolol—Chest pain—Memantine—Alzheimer's disease	0.000234	0.000856	CcSEcCtD
Betaxolol—Arthralgia—Memantine—Alzheimer's disease	0.000234	0.000856	CcSEcCtD
Betaxolol—Myalgia—Memantine—Alzheimer's disease	0.000234	0.000856	CcSEcCtD
Betaxolol—Anxiety—Memantine—Alzheimer's disease	0.000234	0.000853	CcSEcCtD
Betaxolol—Discomfort—Memantine—Alzheimer's disease	0.000232	0.000845	CcSEcCtD
Betaxolol—Hypotension—Donepezil—Alzheimer's disease	0.000231	0.000844	CcSEcCtD
Betaxolol—Myalgia—Rivastigmine—Alzheimer's disease	0.000229	0.000837	CcSEcCtD
Betaxolol—Chest pain—Rivastigmine—Alzheimer's disease	0.000229	0.000837	CcSEcCtD
Betaxolol—Arthralgia—Rivastigmine—Alzheimer's disease	0.000229	0.000837	CcSEcCtD
Betaxolol—Dry mouth—Memantine—Alzheimer's disease	0.000229	0.000837	CcSEcCtD
Betaxolol—Asthenia—Galantamine—Alzheimer's disease	0.000229	0.000836	CcSEcCtD
Betaxolol—Anxiety—Rivastigmine—Alzheimer's disease	0.000229	0.000834	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000228	0.000831	CcSEcCtD
Betaxolol—Confusional state—Memantine—Alzheimer's disease	0.000227	0.000827	CcSEcCtD
Betaxolol—Discomfort—Rivastigmine—Alzheimer's disease	0.000227	0.000827	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000226	0.000823	CcSEcCtD
Betaxolol—Oedema—Memantine—Alzheimer's disease	0.000225	0.00082	CcSEcCtD
Betaxolol—Dry mouth—Rivastigmine—Alzheimer's disease	0.000224	0.000819	CcSEcCtD
Betaxolol—Insomnia—Donepezil—Alzheimer's disease	0.000224	0.000817	CcSEcCtD
Betaxolol—Infection—Memantine—Alzheimer's disease	0.000223	0.000815	CcSEcCtD
Betaxolol—Paraesthesia—Donepezil—Alzheimer's disease	0.000222	0.000811	CcSEcCtD
Betaxolol—Confusional state—Rivastigmine—Alzheimer's disease	0.000222	0.000809	CcSEcCtD
Betaxolol—Shock—Memantine—Alzheimer's disease	0.000221	0.000807	CcSEcCtD
Betaxolol—Dyspnoea—Donepezil—Alzheimer's disease	0.000221	0.000805	CcSEcCtD
Betaxolol—Nervous system disorder—Memantine—Alzheimer's disease	0.00022	0.000804	CcSEcCtD
Betaxolol—Thrombocytopenia—Memantine—Alzheimer's disease	0.00022	0.000803	CcSEcCtD
Betaxolol—Oedema—Rivastigmine—Alzheimer's disease	0.00022	0.000802	CcSEcCtD
Betaxolol—Tachycardia—Memantine—Alzheimer's disease	0.000219	0.0008	CcSEcCtD
Betaxolol—Diarrhoea—Galantamine—Alzheimer's disease	0.000219	0.000798	CcSEcCtD
Betaxolol—Infection—Rivastigmine—Alzheimer's disease	0.000218	0.000797	CcSEcCtD
Betaxolol—Skin disorder—Memantine—Alzheimer's disease	0.000218	0.000797	CcSEcCtD
Betaxolol—Dyspepsia—Donepezil—Alzheimer's disease	0.000218	0.000795	CcSEcCtD
Betaxolol—Hyperhidrosis—Memantine—Alzheimer's disease	0.000217	0.000793	CcSEcCtD
Betaxolol—Shock—Rivastigmine—Alzheimer's disease	0.000216	0.000789	CcSEcCtD
Betaxolol—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000216	0.000787	CcSEcCtD
Betaxolol—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000215	0.000786	CcSEcCtD
Betaxolol—Decreased appetite—Donepezil—Alzheimer's disease	0.000215	0.000785	CcSEcCtD
Betaxolol—Tachycardia—Rivastigmine—Alzheimer's disease	0.000215	0.000783	CcSEcCtD
Betaxolol—Anorexia—Memantine—Alzheimer's disease	0.000214	0.000782	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000214	0.00078	CcSEcCtD
Betaxolol—Skin disorder—Rivastigmine—Alzheimer's disease	0.000214	0.000779	CcSEcCtD
Betaxolol—Fatigue—Donepezil—Alzheimer's disease	0.000213	0.000779	CcSEcCtD
Betaxolol—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000213	0.000776	CcSEcCtD
Betaxolol—Pain—Donepezil—Alzheimer's disease	0.000212	0.000772	CcSEcCtD
Betaxolol—Constipation—Donepezil—Alzheimer's disease	0.000212	0.000772	CcSEcCtD
Betaxolol—Dizziness—Galantamine—Alzheimer's disease	0.000211	0.000771	CcSEcCtD
Betaxolol—Hypotension—Memantine—Alzheimer's disease	0.00021	0.000766	CcSEcCtD
Betaxolol—Anorexia—Rivastigmine—Alzheimer's disease	0.00021	0.000765	CcSEcCtD
Betaxolol—Hypotension—Rivastigmine—Alzheimer's disease	0.000205	0.00075	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000205	0.000747	CcSEcCtD
Betaxolol—Feeling abnormal—Donepezil—Alzheimer's disease	0.000204	0.000744	CcSEcCtD
Betaxolol—Insomnia—Memantine—Alzheimer's disease	0.000203	0.000742	CcSEcCtD
Betaxolol—Vomiting—Galantamine—Alzheimer's disease	0.000203	0.000741	CcSEcCtD
Betaxolol—Paraesthesia—Memantine—Alzheimer's disease	0.000202	0.000736	CcSEcCtD
Betaxolol—Rash—Galantamine—Alzheimer's disease	0.000201	0.000735	CcSEcCtD
Betaxolol—Dermatitis—Galantamine—Alzheimer's disease	0.000201	0.000734	CcSEcCtD
Betaxolol—Dyspnoea—Memantine—Alzheimer's disease	0.0002	0.000731	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.0002	0.000731	CcSEcCtD
Betaxolol—Headache—Galantamine—Alzheimer's disease	0.0002	0.00073	CcSEcCtD
Betaxolol—Insomnia—Rivastigmine—Alzheimer's disease	0.000199	0.000726	CcSEcCtD
Betaxolol—Dyspepsia—Memantine—Alzheimer's disease	0.000198	0.000722	CcSEcCtD
Betaxolol—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000197	0.00072	CcSEcCtD
Betaxolol—Urticaria—Donepezil—Alzheimer's disease	0.000197	0.000718	CcSEcCtD
Betaxolol—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000196	0.000715	CcSEcCtD
Betaxolol—Body temperature increased—Donepezil—Alzheimer's disease	0.000196	0.000714	CcSEcCtD
Betaxolol—Decreased appetite—Memantine—Alzheimer's disease	0.000195	0.000713	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000194	0.000708	CcSEcCtD
Betaxolol—Fatigue—Memantine—Alzheimer's disease	0.000194	0.000707	CcSEcCtD
Betaxolol—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000194	0.000706	CcSEcCtD
Betaxolol—Pain—Memantine—Alzheimer's disease	0.000192	0.000701	CcSEcCtD
Betaxolol—Constipation—Memantine—Alzheimer's disease	0.000192	0.000701	CcSEcCtD
Betaxolol—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000191	0.000697	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00019	0.000693	CcSEcCtD
Betaxolol—Nausea—Galantamine—Alzheimer's disease	0.00019	0.000692	CcSEcCtD
Betaxolol—Fatigue—Rivastigmine—Alzheimer's disease	0.00019	0.000692	CcSEcCtD
Betaxolol—Pain—Rivastigmine—Alzheimer's disease	0.000188	0.000686	CcSEcCtD
Betaxolol—Constipation—Rivastigmine—Alzheimer's disease	0.000188	0.000686	CcSEcCtD
Betaxolol—Feeling abnormal—Memantine—Alzheimer's disease	0.000185	0.000676	CcSEcCtD
Betaxolol—Hypersensitivity—Donepezil—Alzheimer's disease	0.000182	0.000666	CcSEcCtD
Betaxolol—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000181	0.000661	CcSEcCtD
Betaxolol—Urticaria—Memantine—Alzheimer's disease	0.000179	0.000652	CcSEcCtD
Betaxolol—Body temperature increased—Memantine—Alzheimer's disease	0.000178	0.000648	CcSEcCtD
Betaxolol—Asthenia—Donepezil—Alzheimer's disease	0.000178	0.000648	CcSEcCtD
Betaxolol—Pruritus—Donepezil—Alzheimer's disease	0.000175	0.000639	CcSEcCtD
Betaxolol—Urticaria—Rivastigmine—Alzheimer's disease	0.000175	0.000637	CcSEcCtD
Betaxolol—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000174	0.000634	CcSEcCtD
Betaxolol—Propranolol—CYP2D6—Alzheimer's disease	0.000172	0.0479	CrCbGaD
Betaxolol—Diarrhoea—Donepezil—Alzheimer's disease	0.000169	0.000618	CcSEcCtD
Betaxolol—Hypersensitivity—Memantine—Alzheimer's disease	0.000166	0.000604	CcSEcCtD
Betaxolol—Dizziness—Donepezil—Alzheimer's disease	0.000164	0.000597	CcSEcCtD
Betaxolol—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000162	0.000591	CcSEcCtD
Betaxolol—Asthenia—Memantine—Alzheimer's disease	0.000161	0.000588	CcSEcCtD
Betaxolol—Pruritus—Memantine—Alzheimer's disease	0.000159	0.00058	CcSEcCtD
Betaxolol—Asthenia—Rivastigmine—Alzheimer's disease	0.000158	0.000576	CcSEcCtD
Betaxolol—Vomiting—Donepezil—Alzheimer's disease	0.000157	0.000574	CcSEcCtD
Betaxolol—Rash—Donepezil—Alzheimer's disease	0.000156	0.00057	CcSEcCtD
Betaxolol—Dermatitis—Donepezil—Alzheimer's disease	0.000156	0.000569	CcSEcCtD
Betaxolol—Pruritus—Rivastigmine—Alzheimer's disease	0.000156	0.000568	CcSEcCtD
Betaxolol—Headache—Donepezil—Alzheimer's disease	0.000155	0.000566	CcSEcCtD
Betaxolol—Diarrhoea—Memantine—Alzheimer's disease	0.000154	0.000561	CcSEcCtD
Betaxolol—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00015	0.000549	CcSEcCtD
Betaxolol—Dizziness—Memantine—Alzheimer's disease	0.000149	0.000542	CcSEcCtD
Betaxolol—Nausea—Donepezil—Alzheimer's disease	0.000147	0.000537	CcSEcCtD
Betaxolol—Dizziness—Rivastigmine—Alzheimer's disease	0.000145	0.000531	CcSEcCtD
Betaxolol—Vomiting—Memantine—Alzheimer's disease	0.000143	0.000521	CcSEcCtD
Betaxolol—Rash—Memantine—Alzheimer's disease	0.000142	0.000517	CcSEcCtD
Betaxolol—Dermatitis—Memantine—Alzheimer's disease	0.000142	0.000517	CcSEcCtD
Betaxolol—Headache—Memantine—Alzheimer's disease	0.000141	0.000514	CcSEcCtD
Betaxolol—Vomiting—Rivastigmine—Alzheimer's disease	0.00014	0.00051	CcSEcCtD
Betaxolol—Rash—Rivastigmine—Alzheimer's disease	0.000139	0.000506	CcSEcCtD
Betaxolol—Dermatitis—Rivastigmine—Alzheimer's disease	0.000138	0.000505	CcSEcCtD
Betaxolol—Headache—Rivastigmine—Alzheimer's disease	0.000138	0.000503	CcSEcCtD
Betaxolol—Nausea—Memantine—Alzheimer's disease	0.000133	0.000487	CcSEcCtD
Betaxolol—Nausea—Rivastigmine—Alzheimer's disease	0.000131	0.000477	CcSEcCtD
Betaxolol—ADRB2—GPCR ligand binding—CCR5—Alzheimer's disease	2.9e-05	0.00118	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—IAPP—Alzheimer's disease	2.89e-05	0.00118	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—CRH—Alzheimer's disease	2.87e-05	0.00117	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PYY—Alzheimer's disease	2.87e-05	0.00117	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—DHCR24—Alzheimer's disease	2.84e-05	0.00115	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—HTR2A—Alzheimer's disease	2.84e-05	0.00115	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—CRH—Alzheimer's disease	2.81e-05	0.00114	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—NPS—Alzheimer's disease	2.72e-05	0.00111	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—NPY—Alzheimer's disease	2.7e-05	0.0011	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—IAPP—Alzheimer's disease	2.69e-05	0.00109	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—NPS—Alzheimer's disease	2.66e-05	0.00108	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—NPY—Alzheimer's disease	2.65e-05	0.00108	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—IAPP—Alzheimer's disease	2.63e-05	0.00107	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—CRH—Alzheimer's disease	2.61e-05	0.00106	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—GAB2—Alzheimer's disease	2.6e-05	0.00106	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—SST—Alzheimer's disease	2.6e-05	0.00106	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—CRH—Alzheimer's disease	2.55e-05	0.00104	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CDK5—Alzheimer's disease	2.54e-05	0.00104	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—F2—Alzheimer's disease	2.54e-05	0.00103	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—SST—Alzheimer's disease	2.54e-05	0.00103	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—GAB2—Alzheimer's disease	2.54e-05	0.00103	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—APP—Alzheimer's disease	2.53e-05	0.00103	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CDK5—Alzheimer's disease	2.49e-05	0.00101	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—F2—Alzheimer's disease	2.49e-05	0.00101	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—APP—Alzheimer's disease	2.48e-05	0.00101	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—NPS—Alzheimer's disease	2.47e-05	0.00101	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PPP3CA—Alzheimer's disease	2.46e-05	0.001	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HTR6—Alzheimer's disease	2.45e-05	0.000997	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—NPS—Alzheimer's disease	2.42e-05	0.000985	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CA4—Alzheimer's disease	2.41e-05	0.000982	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PPP3CA—Alzheimer's disease	2.41e-05	0.00098	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—DHCR24—Alzheimer's disease	2.4e-05	0.000978	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HTR6—Alzheimer's disease	2.4e-05	0.000975	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—PLCB1—Alzheimer's disease	2.39e-05	0.000973	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—SST—Alzheimer's disease	2.36e-05	0.00096	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—GAB2—Alzheimer's disease	2.36e-05	0.00096	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—PLCB1—Alzheimer's disease	2.34e-05	0.000951	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—GAB2—Alzheimer's disease	2.31e-05	0.00094	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—SST—Alzheimer's disease	2.31e-05	0.00094	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—APP—Alzheimer's disease	2.3e-05	0.000936	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	2.27e-05	0.000923	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—CCL2—Alzheimer's disease	2.27e-05	0.000922	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—APP—Alzheimer's disease	2.25e-05	0.000916	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.24e-05	0.000912	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PSENEN—Alzheimer's disease	2.22e-05	0.000905	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—CCL2—Alzheimer's disease	2.22e-05	0.000902	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APH1A—Alzheimer's disease	2.19e-05	0.000893	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PSENEN—Alzheimer's disease	2.17e-05	0.000885	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PLCB1—Alzheimer's disease	2.17e-05	0.000883	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	2.15e-05	0.000875	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APH1A—Alzheimer's disease	2.14e-05	0.000873	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NCSTN—Alzheimer's disease	2.13e-05	0.000869	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PLCB1—Alzheimer's disease	2.12e-05	0.000864	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NCSTN—Alzheimer's disease	2.09e-05	0.00085	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—LRP1—Alzheimer's disease	2.08e-05	0.000848	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PLD3—Alzheimer's disease	2.05e-05	0.000835	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CA4—Alzheimer's disease	2.04e-05	0.000832	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—LRP1—Alzheimer's disease	2.04e-05	0.000829	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GAL—Alzheimer's disease	2.03e-05	0.000828	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GFAP—Alzheimer's disease	2.03e-05	0.000828	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2e-05	0.000813	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GAL—Alzheimer's disease	1.99e-05	0.00081	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GFAP—Alzheimer's disease	1.99e-05	0.00081	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	1.97e-05	0.000801	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	1.92e-05	0.000782	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	1.89e-05	0.000771	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.83e-05	0.000744	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	1.82e-05	0.000741	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—A2M—Alzheimer's disease	1.79e-05	0.00073	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.77e-05	0.000719	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—A2M—Alzheimer's disease	1.75e-05	0.000714	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PLD3—Alzheimer's disease	1.74e-05	0.000707	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.74e-05	0.000707	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PSEN2—Alzheimer's disease	1.74e-05	0.000707	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.73e-05	0.000704	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.72e-05	0.000699	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PSEN2—Alzheimer's disease	1.7e-05	0.000691	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—CCR5—Alzheimer's disease	1.67e-05	0.000682	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	1.67e-05	0.000678	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.64e-05	0.000667	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—CCR5—Alzheimer's disease	1.64e-05	0.000667	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.63e-05	0.000663	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PRKCG—Alzheimer's disease	1.6e-05	0.000653	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	1.6e-05	0.000653	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.6e-05	0.000652	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NPY—Alzheimer's disease	1.6e-05	0.00065	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IAPP—Alzheimer's disease	1.59e-05	0.000646	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PRKCG—Alzheimer's disease	1.57e-05	0.000639	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NPY—Alzheimer's disease	1.56e-05	0.000636	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IAPP—Alzheimer's disease	1.55e-05	0.000632	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ND1—Alzheimer's disease	1.55e-05	0.00063	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CRH—Alzheimer's disease	1.54e-05	0.000627	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—CCR5—Alzheimer's disease	1.52e-05	0.000619	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.51e-05	0.000616	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CRH—Alzheimer's disease	1.51e-05	0.000614	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—HTR2A—Alzheimer's disease	1.49e-05	0.000606	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—CCR5—Alzheimer's disease	1.49e-05	0.000605	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NPS—Alzheimer's disease	1.46e-05	0.000595	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—HTR2A—Alzheimer's disease	1.46e-05	0.000592	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.45e-05	0.000592	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—F2—Alzheimer's disease	1.44e-05	0.000585	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PTK2B—Alzheimer's disease	1.43e-05	0.000583	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NPS—Alzheimer's disease	1.43e-05	0.000582	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PPP3CA—Alzheimer's disease	1.42e-05	0.000579	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—F2—Alzheimer's disease	1.41e-05	0.000572	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PTK2B—Alzheimer's disease	1.4e-05	0.000571	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—SST—Alzheimer's disease	1.39e-05	0.000567	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GAB2—Alzheimer's disease	1.39e-05	0.000567	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NTRK2—Alzheimer's disease	1.39e-05	0.000567	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—CALM1—Alzheimer's disease	1.39e-05	0.000565	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.38e-05	0.000564	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GSK3A—Alzheimer's disease	1.38e-05	0.000562	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NTRK2—Alzheimer's disease	1.36e-05	0.000555	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GAB2—Alzheimer's disease	1.36e-05	0.000555	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SST—Alzheimer's disease	1.36e-05	0.000555	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APP—Alzheimer's disease	1.36e-05	0.000553	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—CALM1—Alzheimer's disease	1.36e-05	0.000553	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GSK3A—Alzheimer's disease	1.35e-05	0.00055	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APP—Alzheimer's disease	1.33e-05	0.000541	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—F2—Alzheimer's disease	1.3e-05	0.000531	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PLCB1—Alzheimer's disease	1.28e-05	0.000522	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—F2—Alzheimer's disease	1.28e-05	0.000519	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PLCB1—Alzheimer's disease	1.25e-05	0.00051	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NGFR—Alzheimer's disease	1.2e-05	0.000487	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.19e-05	0.000486	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—CREB1—Alzheimer's disease	1.19e-05	0.000484	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.18e-05	0.00048	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.18e-05	0.00048	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NGFR—Alzheimer's disease	1.17e-05	0.000476	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ADAM10—Alzheimer's disease	1.17e-05	0.000475	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—CCL2—Alzheimer's disease	1.16e-05	0.000473	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—CREB1—Alzheimer's disease	1.16e-05	0.000473	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ADAM10—Alzheimer's disease	1.14e-05	0.000465	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—CCL2—Alzheimer's disease	1.14e-05	0.000463	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—MAOB—Alzheimer's disease	1.13e-05	0.00046	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—S100B—Alzheimer's disease	1.1e-05	0.00045	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	1.09e-05	0.000443	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.09e-05	0.000442	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—S100B—Alzheimer's disease	1.08e-05	0.00044	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IGF2—Alzheimer's disease	1.05e-05	0.000428	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—A2M—Alzheimer's disease	1.05e-05	0.000427	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IGF2—Alzheimer's disease	1.03e-05	0.000419	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IGF1R—Alzheimer's disease	1.02e-05	0.000414	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CHAT—Alzheimer's disease	9.98e-06	0.000406	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—TPI1—Alzheimer's disease	9.98e-06	0.000406	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IGF1R—Alzheimer's disease	9.95e-06	0.000405	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—LPL—Alzheimer's disease	9.75e-06	0.000397	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MEF2C—Alzheimer's disease	9.66e-06	0.000393	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—MAOB—Alzheimer's disease	9.57e-06	0.000389	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—LPL—Alzheimer's disease	9.54e-06	0.000388	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PRKCG—Alzheimer's disease	9.48e-06	0.000386	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MEF2C—Alzheimer's disease	9.45e-06	0.000385	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PRKCG—Alzheimer's disease	9.27e-06	0.000377	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NGF—Alzheimer's disease	9.23e-06	0.000376	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	9.21e-06	0.000375	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ACHE—Alzheimer's disease	9.13e-06	0.000372	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	9.11e-06	0.000371	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NGF—Alzheimer's disease	9.03e-06	0.000368	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	9.03e-06	0.000368	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	9.02e-06	0.000367	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CCR5—Alzheimer's disease	8.98e-06	0.000366	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—A2M—Alzheimer's disease	8.89e-06	0.000362	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HTR2A—Alzheimer's disease	8.79e-06	0.000358	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CCR5—Alzheimer's disease	8.79e-06	0.000358	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HTR2A—Alzheimer's disease	8.6e-06	0.00035	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ENO1—Alzheimer's disease	8.56e-06	0.000348	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	8.56e-06	0.000348	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CALM1—Alzheimer's disease	8.2e-06	0.000334	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—LEP—Alzheimer's disease	8.17e-06	0.000333	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APOE—Alzheimer's disease	8.17e-06	0.000333	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CAV1—Alzheimer's disease	8.1e-06	0.00033	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CALM1—Alzheimer's disease	8.02e-06	0.000327	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APOE—Alzheimer's disease	7.99e-06	0.000325	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—LEP—Alzheimer's disease	7.99e-06	0.000325	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—BCHE—Alzheimer's disease	7.96e-06	0.000324	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	7.93e-06	0.000323	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CAV1—Alzheimer's disease	7.92e-06	0.000322	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ESR1—Alzheimer's disease	7.8e-06	0.000318	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ACHE—Alzheimer's disease	7.74e-06	0.000315	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—F2—Alzheimer's disease	7.71e-06	0.000314	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	7.65e-06	0.000311	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ESR1—Alzheimer's disease	7.63e-06	0.000311	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NOTCH1—Alzheimer's disease	7.54e-06	0.000307	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—F2—Alzheimer's disease	7.54e-06	0.000307	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	7.51e-06	0.000306	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NOTCH1—Alzheimer's disease	7.38e-06	0.0003	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	7.28e-06	0.000296	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ENO1—Alzheimer's disease	7.25e-06	0.000295	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	7.25e-06	0.000295	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	7.11e-06	0.000289	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GSK3B—Alzheimer's disease	7.08e-06	0.000288	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CREB1—Alzheimer's disease	7.02e-06	0.000286	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—INS—Alzheimer's disease	6.98e-06	0.000284	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GSK3B—Alzheimer's disease	6.92e-06	0.000282	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CCL2—Alzheimer's disease	6.87e-06	0.00028	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CREB1—Alzheimer's disease	6.87e-06	0.00028	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—INS—Alzheimer's disease	6.83e-06	0.000278	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IGF1—Alzheimer's disease	6.75e-06	0.000275	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—BCHE—Alzheimer's disease	6.74e-06	0.000274	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CCL2—Alzheimer's disease	6.72e-06	0.000273	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IGF1—Alzheimer's disease	6.6e-06	0.000269	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	6.36e-06	0.000259	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	6.27e-06	0.000255	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	6.24e-06	0.000254	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.24e-06	0.000254	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	6.17e-06	0.000251	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NOS3—Alzheimer's disease	6.12e-06	0.000249	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NOS3—Alzheimer's disease	5.99e-06	0.000244	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—LPL—Alzheimer's disease	5.71e-06	0.000232	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	5.31e-06	0.000216	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	5.29e-06	0.000215	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	5.25e-06	0.000214	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	5.2e-06	0.000212	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	5.16e-06	0.00021	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	5.14e-06	0.000209	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—AKT1—Alzheimer's disease	5.13e-06	0.000209	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CASP3—Alzheimer's disease	5.08e-06	0.000207	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—IL6—Alzheimer's disease	5.05e-06	0.000206	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LPL—Alzheimer's disease	4.84e-06	0.000197	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CALM1—Alzheimer's disease	4.8e-06	0.000196	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOE—Alzheimer's disease	4.79e-06	0.000195	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	4.78e-06	0.000194	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	4.76e-06	0.000194	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CAV1—Alzheimer's disease	4.74e-06	0.000193	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MAPK8—Alzheimer's disease	4.67e-06	0.00019	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—AKT1—Alzheimer's disease	4.66e-06	0.00019	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	4.41e-06	0.00018	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	4.36e-06	0.000177	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—VEGFA—Alzheimer's disease	4.31e-06	0.000176	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PPARG—Alzheimer's disease	4.17e-06	0.00017	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—INS—Alzheimer's disease	4.09e-06	0.000166	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CALM1—Alzheimer's disease	4.07e-06	0.000166	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOE—Alzheimer's disease	4.06e-06	0.000165	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	4.05e-06	0.000165	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CAV1—Alzheimer's disease	4.02e-06	0.000164	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TGFB1—Alzheimer's disease	3.96e-06	0.000161	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NOS3—Alzheimer's disease	3.59e-06	0.000146	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PPARG—Alzheimer's disease	3.53e-06	0.000144	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—INS—Alzheimer's disease	3.46e-06	0.000141	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	3.33e-06	0.000136	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	3.28e-06	0.000134	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TP53—Alzheimer's disease	3.26e-06	0.000133	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	3.05e-06	0.000124	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NOS3—Alzheimer's disease	3.04e-06	0.000124	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IL6—Alzheimer's disease	2.98e-06	0.000121	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	2.81e-06	0.000115	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	2.78e-06	0.000113	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AKT1—Alzheimer's disease	2.75e-06	0.000112	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.65e-06	6.71e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—AKT1—Alzheimer's disease	1.4e-06	5.69e-05	CbGpPWpGaD
